Processing
Comprehensive, reliable answers for heme malignancies with customized Archer™ NGS assays
How can specific NGS assay content, chemistry, and analysis make a difference for heme malignancy answers? Hear from experts at Duke on their experience implementing Archer FUSIONPlex™ and VARIANTPlex™ custom NGS assays for profiling heme malignancies. Learn why they chose these panels, how they were implemented in the lab, and their experience with the chemistry, workflows, and analysis software. Case studies demonstrating the difference these assays make for heme malignancy answers will be presented.
Presenters
Barbara Anderson, PhD, MB (ASCP)CM
Analytical Specialist
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System
Ludmila Francescatto, PhD
Laboratory Genetics & Genomics Fellow
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System
Casey Geaney, MBA
Director of Product Management, NGS Software
Integrated DNA Technologies